Market

Summit Therapeutics stock initiated with Buy rating at UBS on cancer drug potential

Summit Therapeutics stock initiated with Buy rating at UBS on cancer drug potential
Read More

Related Posts

US Treasury Secretary Bessent holds constructive call with China

US Treasury Secretary Bessent holds constructive call w...

Mendonca, Wabtec president, sells $433k in WAB stock

Mendonca, Wabtec president, sells $433k in WAB stock

This Tesla move could help the EV maker shake a sales slump

This Tesla move could help the EV maker shake a sales s...

Empire State Realty Trust declares Q4 dividend of $0.035 per share

Empire State Realty Trust declares Q4 dividend of $0.03...

New York Times sues Perplexity AI for ’illegal’ copying of content

New York Times sues Perplexity AI for ’illegal’ copying...

Brown Forman stock price target raised to $32 by Evercore ISI

Brown Forman stock price target raised to $32 by Everco...